Aspenbio Pharma ($APPY) - Oversold - views

Aspenbio Pharma has hit a technical signal on 3 different technical indicators. APPY is in the Health Care sector. The technical signals indicate that the stock is Oversold right now. The 3 indicators: Commodity Channel Index, Relative Strength Index and the Fast Stochastics were all triggered based on the last closing price of $0.69 on Feb 14.

There is currently one analyst covering the company and is not offering a buy recommendation on the stock. The current consensus estimate for quarterly earnings is per share. The analyst covering the company is forecasting earnings of per share. The consensus estimate for next years' earnings is per share, which represents forecast growth of 0.0%.

Over the last 52 weeks, the stock has been trading between $0.51 and $3.80. More recently in the last 4 weeks, the stock has been trading between $0.69 and $0.98. Yesterday the stock traded between $0.69 and $0.75. The stock currently has a PE ratio of 0.0.

Aspenbio Pharma is trading -19.3% from its 20-day simple moving average (SMA) of $0.86 and -39.2% from its 50-day SMA and -54.26% from its 200-day SMA. Average daily volume over the last 30 days has been 27,319 shares.

At yesterdays close: the RSI was at 16.4, the CCI was at -142.4 and the Fast Stochastic was at 0.0. APPY closed yesterday at $0.69, on volume of 45,648 shares as compared to an average volume of 27,319 over the last 4 weeks.

AspenBio Pharma, Inc. operates as an emerging biomedical company focused on obtaining the United States FDA clearance for its lead product, AppyScore. Its research and development activities primarily focus on a human appendicitis blood-based test. The companyÂ’s lead product candidate, AppyScore, is a blood-based diagnostic test to help physicians manage patients who enter emergency rooms complaining of abdominal pain and suspected of having acute appendicitis. It is also developing animal healthcare products focusing on reproduction. The company was formerly known as AspenBio, Inc. and changed its name to AspenBio Pharma, Inc. on September 26, 2005. AspenBio Pharma, Inc. was founded in 2000 and is based in Castle Rock, Colorado.

Technical Indicators should be used as the starting point for further analysis. These indicators are provided as a guide to help you determine what assets to analyze. The technical indicators used in this article can indicate that an asset is either overbought or oversold, but that indication could be the result of a fundamental or other type of event like an earnings announcement.

To learn more about technical analysis, please refer to our technical analysis primer.